A novel microwave synthesis of quinoline-3-carboxylic acid derivatives for treatment against human African trypanosomiasis.

Mol Divers

Natural Product and Medicinal Chemistry Research Group, Division of Pharmaceutical chemistry, Rhodes University, Grahamstown 6140, South Africa.

Published: November 2012

A series of quinoline-3-carboxylic acid derivatives has been synthesized with easy reaction conditions (in aqueous micellar microreactors and using microwave irradiation) and tested for its biological activity against human African trypanosomiasis (HAT). From this series, several derivatives of quinoline-3-carboxylic acid such as 23 and 24 exhibited potent activity against Trypanosoma brucei in vitro and had low cytotoxicity. The combination of electron withdrawing and donating groups in the structure seems to be the crucial factor to inhibit T. brucei.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11030-012-9401-2DOI Listing

Publication Analysis

Top Keywords

quinoline-3-carboxylic acid
12
acid derivatives
8
human african
8
african trypanosomiasis
8
novel microwave
4
microwave synthesis
4
synthesis quinoline-3-carboxylic
4
derivatives treatment
4
treatment human
4
trypanosomiasis series
4

Similar Publications

Lowering hepatitis B surface antigen (HBsAg) levels from covalently closed circular DNA (cccDNA) and the integrated genome could reduce the persistence of hepatitis B virus (HBV) infection. Since HBV replication occurs in the liver and to ameliorate the peripheral neuropathy observed with a first-generation tricyclic 4-pyridone PAPD5/7 inhibitor () having high systemic exposure, we focused on increasing the hepatocyte concentration and reducing plasma levels. Optimization of a novel series of PAPD5/7 inhibitors that decrease HBsAg levels led to the tetracyclic 2-pyridone , which was similarly potent to and but showed dramatically higher rodent liver-to-plasma ratios.

View Article and Find Full Text PDF

The higher prevalence of cancer and the unmet need for antioxidant/anti-inflammatory chemotherapeutic compounds with little side effect are of utmost importance. In addition, the increased likelihood of failure in clinical trials along with increasing development costs may have diminished the range of choices among newer drugs for clinical use. This has dictated the necessity to seek out novel medications by repurposing as it needs less time, effort, and resources to explore new uses of a current or unsuccessful medication.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers developed a NiO@FeO nanocomposite that efficiently degrades the antibiotic ciprofloxacin through a catalytic ozonation process, achieving 100% removal at optimal conditions.
  • * The study demonstrated the nanocatalyst's high performance and stability, maintaining 88.37% efficiency after multiple uses, making it a promising solution for treating pharmaceutical contaminants in water.
View Article and Find Full Text PDF

Novel antibacterial agents needed constantly to counter the ever emergent resistance development to commercially available drugs; one of the effective synthetic antibacterial classes is fluoroquinolone (FQ). This study includes structure activity relationship based design and synthesis of novel fluoroquinolone molecules active against resistant pathogens bearing mutations of DNA gyrase and/or topoisomerase IV which also express efflux pumps. Here, series of compounds were prepared by treating 1-cyclopropyl-6,7-difluoro-8-methoxy-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid as a core with various 4-substituted-3,3-dialkyl piperidines as side chains, through conventional synthetic approaches.

View Article and Find Full Text PDF

The small molecule 8-methoxy-2-oxo-1,2,4,5-tetrahydrocyclopenta[de]quinoline-3-carboxylic acid () behaves as a reactive non-fluorescent Michael acceptor, which after reaction with thiols becomes fluorescent, and an efficient Eu antenna, after self-assembling with this cation in water. This behavior makes a highly selective GSH biosensor, which has demonstrated high potential for studies in murine and human cells of the immune system (CD4 T, CD8 T, and B cells) using flow cytometry. GSH can be monitored by the fluorescence of the product of addition to (445 nm) or by the luminescence of Eu (592 nm).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!